Lundbeck unveils migraine data for eptinezumab at international congress
14 September, 2025
George Eldridge
14 September, 2025
Rezatapopt shows promise in phase 2 trial for TP53 Y220C solid tumours
14 September, 2025
Quotient Sciences and CPI launch RNA drug development venture
14 September, 2025
Bluejay begins phase 3 trial of brelovitug for hepatitis D
14 September, 2025
Eisai unveils promising phase 1b data for narcolepsy drug E2086
14 September, 2025
AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025
14 September, 2025
Centre stage
14 September, 2025
Resolution Therapeutics doses first patient in EMERALD study of RTX001
14 September, 2025
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago